Upregulated and overexpressed TGF-β has been shown to induce stromal proliferation in PDAC tumor microenvironment, promote EMT leading to metastases and consequently is a potential target for cancer therapy (Pickup et al., 2013; David et al., 2016; Hussain et al., 2018). The gene discussed is TGFB1; the disease is neoplasm.